Copyright
©The Author(s) 2020.
World J Gastroenterol. Apr 28, 2020; 26(16): 1912-1925
Published online Apr 28, 2020. doi: 10.3748/wjg.v26.i16.1912
Published online Apr 28, 2020. doi: 10.3748/wjg.v26.i16.1912
Table 4 Serum levels of pro and anti-inflammatory cytokines in inflammatory bowel disease and colorectal cancer patients
| Cytokines | IBD patients | CRC patients | P value (U-test) |
| TGFB1 (ng/mL) | 11.19 (9.36-20.99) | 22.57 (18.08-29.65) | 0.0008 |
| IL-10 (pg/mL) | 0.4 (0.0-2.8) | 8.29 (6.75-15.12) | 0.000001 |
| IL-6 (pg/mL) | 0.0 (0.0-2.7) | 3.21 (2.03-4.19) | 0.012 |
| IL-23A (pg/mL) | 0.7 (0.0-3.7) | 27.55 (25.35-33.0) | 0.000001 |
| IL-17A (pg/mL) | 0.0 (0.0-0.26) | 2.85 (0.0-9.0) | 0.034 |
- Citation: Velikova TV, Miteva L, Stanilov N, Spassova Z, Stanilova SA. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer. World J Gastroenterol 2020; 26(16): 1912-1925
- URL: https://www.wjgnet.com/1007-9327/full/v26/i16/1912.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i16.1912